Branched-chain amino acids

Biomarker4 papers2 findings

  • Human trial1
  • Humans2

Interventions

1

Glimepiride

downin humans1Moderate certainty

1 study
  1. Glimepiride decreases branched-chain amino acids in humans.

    Human trialtype 2 diabetes and biopsy-confirmed MASLDliver48 weeks

    Distinct metabolomic signatures of SGLT2 inhibitor vs. sulfonylurea in a paired human liver biopsy study · Biochemistry and biophysics reports · 14 Sep 2026

Glimepiride →

Associations

1

Sarcopenic obesity

upin humans1OR 1.555–1.693

1 study
  1. Branched-chain amino acids raise the risk of sarcopenic obesity in humans (ORs: 1.555-1.693, P < 0.01).

    Humans14 years

    Divergent amino acid profiles in sarcopenic obesity versus non-obese sarcopenia: A prospective cohort study in community-dwelling older adults · The journal of nutrition, health & aging · 11 Sep 2026

Sarcopenic obesity →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 3Sep 2026: 6Oct 2026: 010